Tirzepatide , a dual GIP/GLP-1 receptor agonist, demonstrated superior efficacy to semaglutide in a landmark head-to-head trial, with patients receiving ZEPBOUND losing an average of 50 pounds over 72 weeks compared with 33 pounds among WEGOVY-treated patients
Appl Clin Genet (2016) 9:3947
While this type of fat might go along with having a bigger belly you can see on the outside, you can't see visceral fat
3.3 Mast cell degranulating (MCD) peptide Mast cell degranulating (MCD) Peptide, or peptide 401, is a BV polypeptide of 22 amino acids equivalent to apamin because it has two disulfide bridges (Rsinar et al., 2023)
History of Eating Disorders: Because these are powerful appetite suppressants , individuals with a history of anorexia or bulimia require specialized psychological support to prevent a relapse
Neuroprotective Effects: Excessive alcohol consumption can lead to neurotoxicity and impair brain function